NASDAQ:TGAN Transphorm (TGAN) Stock Price, News & Analysis → Do This Today BEFORE Biden Wins in November (From Stansberry Research) (Ad) Free TGAN Stock Alerts $4.89 0.00 (0.00%) (As of 11:18 AM ET) Add Compare Share Share Today's Range$4.88▼$4.9050-Day Range$4.79▼$4.9352-Week Range$1.94▼$4.96Volume19,052 shsAverage Volume376,521 shsMarket Capitalization$302.98 millionP/E RatioN/ADividend YieldN/APrice Target$5.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Transphorm alerts: Email Address Transphorm MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside17.6% Upside$5.75 Price TargetShort InterestBearish4.33% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$7,827 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.31 out of 5 starsComputer And Technology Sector553rd out of 593 stocksSemiconductors & Related Devices Industry85th out of 88 stocks 2.0 Analyst's Opinion Consensus RatingTransphorm has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageTransphorm has received no research coverage in the past 90 days.Read more about Transphorm's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.33% of the float of Transphorm has been sold short.Short Interest Ratio / Days to CoverTransphorm has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in Transphorm has recently increased by 27.61%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldTransphorm does not currently pay a dividend.Dividend GrowthTransphorm does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TGAN. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Transphorm this week, compared to 1 article on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Transphorm insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,827.00 in company stock.Percentage Held by InsidersOnly 2.47% of the stock of Transphorm is held by insiders.Percentage Held by Institutions66.45% of the stock of Transphorm is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Transphorm's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Transphorm is -7.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Transphorm is -7.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTransphorm has a P/B Ratio of 14.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Transphorm's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Transphorm Stock (NASDAQ:TGAN)Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.Read More TGAN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TGAN Stock News HeadlinesMay 2, 2024 | americanbankingnews.comTransphorm (NASDAQ:TGAN) Trading Up 0.4%April 24, 2024 | businesswire.comTransphorm and Weltrend Semiconductor Release New Integrated GaN System-in-PackagesMay 10, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 26, 2024 | prnewswire.comURGENT: The M&A Class Action Firm Encourages Shareholders of Transphorm, Inc. to Take Action Before the Merger Vote on April 9, 2024 - TGANMarch 13, 2024 | businesswire.comTRANSPHORM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Transphorm, Inc. - TGANMarch 12, 2024 | stockhouse.comSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates JNPR, TGAN, HMSTFebruary 20, 2024 | finance.yahoo.comTransphorm Announces Fiscal 2024 Third Quarter Results and Provides Business UpdateFebruary 20, 2024 | businesswire.comTransphorm Announces Fiscal 2024 Third Quarter Results and Provides Business UpdateMay 10, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.January 20, 2024 | stockhouse.comSHAREHOLDER NOTICE: Halper Sadeh LLC Investigates JNPR, TGAN, TASTJanuary 17, 2024 | finance.yahoo.comTransphorm Announces Two 4-Lead TO-247 Devices, Expanding Product Portfolio for High Power Server, Renewable, Industrial Power ConversionJanuary 11, 2024 | tmcnet.comTGAN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Transphorm, Inc. Is Fair to ShareholdersJanuary 11, 2024 | msn.comRenesas to buy Transphorm to expand power portfolio with GaN technologyJanuary 11, 2024 | markets.businessinsider.comTransphorm, Canaan And Other Big Stocks Moving Higher In Thursday's Pre-Market SessionSee More Headlines Receive TGAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Transphorm and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/20/2024Today5/10/2024Next Earnings (Estimated)6/25/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Semiconductors & related devices Sub-IndustryN/A Current SymbolNASDAQ:TGAN CUSIPN/A CIK1715768 Webwww.transphormusa.com Phone805-456-1300FaxN/AEmployees128Year FoundedN/APrice Target and Rating Average Stock Price Target$5.75 High Stock Price Target$8.00 Low Stock Price Target$3.50 Potential Upside/Downside+17.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-30,600,000.00 Net Margins-177.91% Pretax Margin-177.91% Return on Equity-149.03% Return on Assets-86.65% Debt Debt-to-Equity RatioN/A Current Ratio1.69 Quick Ratio0.88 Sales & Book Value Annual Sales$18.76 million Price / Sales16.15 Cash FlowN/A Price / Cash FlowN/A Book Value$0.33 per share Price / Book14.82Miscellaneous Outstanding Shares61,960,000Free Float60,430,000Market Cap$302.98 million OptionableNot Optionable Beta0.59 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Primit A. Parikh Ph.D. (Age 52)Co-Founder, President, CEO & Director Comp: $390.66kMr. Cameron McAulay (Age 48)Chief Financial Officer Comp: $350.66kDr. Umesh K. Mishra Ph.D. (Age 66)Chairman & CTO Comp: $180kMr. Philip ZukSenior Vice President of Business Development & MarketingMr. Tushar DhayagudeVice President of Worldwide Sales & FAEMr. Randy BergHuman Resources LeaderMr. Sal BarlettSenior Vice President of OperationsMore ExecutivesKey CompetitorsArterisNASDAQ:AIPNVENASDAQ:NVECValens SemiconductorNYSE:VLNCanaanNASDAQ:CANQuickLogicNASDAQ:QUIKView All CompetitorsInsidersKatharina G McfarlandSold 840 sharesTotal: $4,074.00 ($4.85/share)Kelly SmalesSold 766 sharesTotal: $3,753.40 ($4.90/share)Kelly SmalesSold 471 sharesTotal: $2,270.22 ($4.82/share)Kelly SmalesSold 766 sharesTotal: $2,987.40 ($3.90/share)Kelly SmalesSold 3,995 sharesTotal: $10,506.85 ($2.63/share)View All Insider Transactions TGAN Stock Analysis - Frequently Asked Questions Should I buy or sell Transphorm stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Transphorm in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TGAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TGAN, but not buy additional shares or sell existing shares. View TGAN analyst ratings or view top-rated stocks. What is Transphorm's stock price target for 2024? 2 brokers have issued twelve-month price targets for Transphorm's shares. Their TGAN share price targets range from $3.50 to $8.00. On average, they predict the company's share price to reach $5.75 in the next year. This suggests a possible upside of 17.6% from the stock's current price. View analysts price targets for TGAN or view top-rated stocks among Wall Street analysts. How have TGAN shares performed in 2024? Transphorm's stock was trading at $3.65 at the beginning of 2024. Since then, TGAN shares have increased by 34.0% and is now trading at $4.89. View the best growth stocks for 2024 here. Are investors shorting Transphorm? Transphorm saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,040,000 shares, an increase of 27.6% from the April 15th total of 815,000 shares. Based on an average daily trading volume, of 215,700 shares, the days-to-cover ratio is presently 4.8 days. Currently, 4.3% of the company's shares are sold short. View Transphorm's Short Interest. When is Transphorm's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 25th 2024. View our TGAN earnings forecast. How were Transphorm's earnings last quarter? Transphorm, Inc. (NASDAQ:TGAN) released its quarterly earnings data on Tuesday, February, 20th. The company reported ($0.20) EPS for the quarter. The business had revenue of $4.67 million for the quarter. Transphorm had a negative trailing twelve-month return on equity of 149.03% and a negative net margin of 177.91%. What other stocks do shareholders of Transphorm own? Based on aggregate information from My MarketBeat watchlists, some companies that other Transphorm investors own include Adobe (ADBE), American Battery Technology (ABML), Capricor Therapeutics (CAPR), Ciena (CIEN), Editas Medicine (EDIT), Eros STX Global (EROS), Grayscale Ethereum Classic Trust (ETC) (ETCG), Freeport-McMoRan (FCX) and Franco-Nevada (FNV). How do I buy shares of Transphorm? Shares of TGAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TGAN) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward PressTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Transphorm, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.